Keywords: astrazeneca, full-year, profits, up, new, products, come

AstraZeneca full-year profits up 20% as new products come good

Article | 24 February 2000

AstraZeneca has posted a strong set of results for 1999, with groupturnover rising 17% (at constant currency rates on a pro forma ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in